ORI Healthcare Fund
Hong Kong SARori-capital.com
Overview
ORI Healthcare Fund is the 2016 vintage venture capital fund of ORI Capital, a firm founded in 2015 that focuses on growth-oriented venture investments in early to mid-stage global biotech companies. The firm's strategy targets innovative companies in diagnostics, drug delivery, and therapeutics, particularly for diseases with high mortality rates such as cancer, metabolic disorders, and neurodegenerative diseases. ORI Capital utilizes a proprietary AI-driven platform called ORIZON to source investments and analyze data on thousands of healthcare companies.
Portfolio Companies
8
Website
ori-capital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CG Oncology | Dec 2020 | Series D | Co-investor |
| Pillar Biosciences | May 2020 | Series C | Lead |
| Enable Injections | Oct 2018 | Series B | - |
| Enable Injections | Oct 2016 | Series A | Lead |
| Pillar Biosciences | May 2016 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.